Besides, HFmrEF patients had a higher PGC1α expression level than HFrEF and HFpEF patients, which could be employed as a potential biomarker for differentiating HF patients from those without HF, as well as for distinguishing HFmrEF from HFrEF and HFpEF. This evidence concerns the gene PPARGC1A and hydrops fetalis.